Market closed

Accolade/$ACCD

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Accolade

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Ticker

$ACCD

Sector

Health Care

Trading on

NASDAQ

Industry

Health Care Providers & Services

Headquarters

Seattle, United States

Employees

2,400

Website

www.accolade.com

Accolade Metrics

BasicAdvanced

$557M

-

-$2.31

2.08 -

Price and volume

Market cap

$557M

Beta

2.08

52-week high

$13.93

52-week low

$3.08

Average daily volume

2.2M

Financial strength

Current ratio

2.63

Quick ratio

2.473

Long term debt to equity

73.658

Total debt to equity

76.004

Interest coverage (TTM)

-34.37%

Management effectiveness

Return on assets (TTM)

-7.50%

Return on equity (TTM)

-48.23%

Valuation

Price to revenue (TTM)

1.193

Price to book

1.77

Price to tangible book (TTM)

-68.93

Price to free cash flow (TTM)

-41.834

Growth

Revenue change (TTM)

14.99%

Earnings per share change (TTM)

39.55%

3-year revenue growth (CAGR)

17.48%

3-year earnings per share growth (CAGR)

9.76%

What the Analysts think about Accolade

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Accolade stock.

Accolade Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Accolade Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Accolade News

AllArticlesVideos

ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD

Business Wire·6 days ago

Why Is Accolade Stock Trading Over 100% On Tuesday?

Benzinga·6 days ago

Transcarent To Acquire Accolade

Business Wire·7 days ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ACCD

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Accolade stock?

Accolade (ACCD) has a market cap of $557M as of January 15, 2025.

What is the P/E ratio for Accolade stock?

The price to earnings (P/E) ratio for Accolade (ACCD) stock is 0 as of January 15, 2025.

Does Accolade stock pay dividends?

No, Accolade (ACCD) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Accolade dividend payment date?

Accolade (ACCD) stock does not pay dividends to its shareholders.

What is the beta indicator for Accolade?

Accolade (ACCD) has a beta rating of 2.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.